SOPH affiliate files Form 144 to sell 8,797 shares

SOPH affiliate filed a Form 144 notice to sell 8,797 shares of Common stock tied to Restricted Stock Units dated 04/02/2026, through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

SOPH affiliate filed a Form 144 notice to sell 8,797 shares of Common stock tied to Restricted Stock Units dated 04/02/2026, through Morgan Stanley Smith Barney LLC. The excerpt also lists three prior 10b5-1 sales by Manuela Valente of 380 shares each on 01/20/2026, 02/19/2026, and 03/19/2026 at $2,040.98, $1,833.88, and $1,818.34, respectively.

Insights

Securities Attorney

Routine Rule 144 notice for RSU-related sale; prior 10b5-1 sales disclosed.

The filing lists a proposed sale of 8,797 shares tied to Restricted Stock Units dated 04/02/2026, and shows three executed 10b5-1 sales of 380 shares each on listed dates. The broker is Morgan Stanley Smith Barney LLC.

Cash‑flow treatment and proceeds recipient are not specified in the excerpt. Timing and conditional language beyond the dates shown are not provided, so follow‑up filings may clarify settlement or broker handling.

Key Figures

Shares proposed for sale: 8,797 shares 10b5-1 sale (Jan): 380 shares 10b5-1 sale (Feb): 380 shares +3 more

6 metrics

Shares proposed for sale 8,797 shares Restricted Stock Units dated 04/02/2026

10b5-1 sale (Jan) 380 shares Sale on 01/20/2026 at $2,040.98

10b5-1 sale (Feb) 380 shares Sale on 02/19/2026 at $1,833.88

10b5-1 sale (Mar) 380 shares Sale on 03/19/2026 at $1,818.34

Broker listed Morgan Stanley Smith Barney LLC Broker for the securities to be sold

Form filing date 04/06/2026 Filer information entry date

Key Terms

Form 144, 10b5-1, Restricted Stock Units

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for MANUELA VALENTE La Piece"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 8797 | 04/02/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SOPH Form 144 notice disclose?

It discloses a proposed sale of 8,797 shares of Common stock linked to RSUs dated 04/02/2026. It also lists prior 10b5-1 sales of 380 shares on three dates with prices shown.

Who executed the recent 10b5-1 sales in the SOPH excerpt?

The excerpt identifies Manuela Valente as the seller for three 10b5-1 transactions of 380 shares each on 01/20/2026, 02/19/2026, and 03/19/2026 with the prices listed.

Which broker is named in the SOPH filing excerpt?

The broker shown is Morgan Stanley Smith Barney LLC, with an address at 1 New York Plaza, 8th Floor, New York, NY. The filing associates the sales with that broker.

Are the sale prices for the 10b5-1 transactions provided for SOPH?

Yes, the excerpt shows prices for each 10b5-1 sale: $2,040.98 on 01/20/2026, $1,833.88 on 02/19/2026, and $1,818.34 on 03/19/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/06/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002009280
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	MANUELA VALENTE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8797	44336.88	68486338	04/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/02/2026	Restricted Stock Units	Issuer			8797	04/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	03/19/2026	380	1818.34
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	02/19/2026	380	1833.88
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/20/2026	380	2040.98

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units on 04/02/2026 and 04/03/2026.
Date of Notice	04/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Manuela Valente
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)